Figure S2. Knockdown efficacy of KDM6A and KDM6B as measured by western blot analysis. (TIF 217 kb
Table (S3). Association between different parameters and histological response in osteosarcoma patie...
Figure S2. Overexpression of Kpnβ1 results in increased sensitivity to Cisplatin. Dose-response curv...
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Figure S4. Upregulation of H3K27me3 levels sensitizes OS to cisplatin. Colony formation ability of O...
Figure S1. mRNA expression of methyltransferases and demethylases in OS cells with or without cispla...
Figure S5. Overexpression of PRKCA reverses the chemosensitization effects of GSK-J4 with regards to...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...
Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...
Table (S3). Association between different parameters and histological response in osteosarcoma patie...
Figure S2. Overexpression of Kpnβ1 results in increased sensitivity to Cisplatin. Dose-response curv...
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
Figure S3. Knockdown of KDM6A or KDM6B enhances cisplatin-induced apoptosis in OS cells. Cleaved Cas...
Figure S4. Upregulation of H3K27me3 levels sensitizes OS to cisplatin. Colony formation ability of O...
Figure S1. mRNA expression of methyltransferases and demethylases in OS cells with or without cispla...
Figure S5. Overexpression of PRKCA reverses the chemosensitization effects of GSK-J4 with regards to...
Figure S3. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(D) ...
List of protein identified exclusively in A2780-CisR control (untreated) cells. Table S2. List of pr...
Figure S1. The effects of Fn14 on cisplatin-resistance in HGSOC cells. (A)-(D) Statistical data of W...
MTT assay of combination of RTK inhibitors with cisplatin. Influence of 48 h preincubation with 1.5 ...
Characterization of MDA-MB231 and cisplatin-resistant MDA-MB231CisR. MDA-MB231 and cisplatin-resista...
NF-κB escalated PIK3CA promoter activity in SP cells. Cisplatin and TNFα but not lithium chloride or...
Figure S4. Fn14 inhibits cisplatin resistance in HGSOC primary cancer cells with p53-R248Q. (A)-(C) ...
Figure S6. Overexpression Fn14 alleviates cisplatin resistance in vivo. (A) Statistical data of West...
Table (S3). Association between different parameters and histological response in osteosarcoma patie...
Figure S2. Overexpression of Kpnβ1 results in increased sensitivity to Cisplatin. Dose-response curv...
Figure S2. Characterization of primary HGSOC cells and identification of p53 status in primary cells...
DOI
Add to ORKG